Albuvirtide in Combination With 3BNC117 in Virologically Suppressed Subjects With HIV-1 Infection
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04819347 |
|
Recruitment Status : Unknown
Verified March 2021 by Frontier Biotechnologies Inc..
Recruitment status was: Not yet recruiting
First Posted : March 26, 2021
Last Update Posted : March 26, 2021
|
Sponsor:
Frontier Biotechnologies Inc.
Information provided by (Responsible Party):
Frontier Biotechnologies Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | June 1, 2022 |
| Estimated Study Completion Date : | December 1, 2022 |